1.Risk factors for pancreatic fistula after pancreaticoduodenectomy and its prevention and treatment measures
Guoquan XING ; Tianqing YAN ; Zhishuo JIA
Journal of Clinical Hepatology 2015;31(12):2110-2113
Pancreatic fistula, a common complication after pancreaticoduodenectomy, is a severe condition with a high mortality. Therefore, early diagnosis of this condition and effective prevention and treatment measures are essential. This article reviews the diagnostic criteria for pancreatic fistula, the risk factors for its development, and research advances in the prevention and treatment of pancreatic fistula.
2. General considerations for clinical data management of antineoplastic drugs
Yadong MIAO ; Min ZHOU ; Xi LI ; Yan WANG ; Po GAO ; Hao YU
Chinese Journal of Clinical Pharmacology and Therapeutics 2022;27(9):1055-1060
With the enormous resources having been invested in oncology drugs development in China in recent years, the Center for Drug Evaluation (CDE) of National Medical Products Administration has been issuing a number of technical guidelines to further standardize the requirements on implementation and registration of domestic oncology clinical trials. As data is the cornerstone of clinical trials, data integrity and quality will directly decide the outcome of clinical studies. Given the specific characteristics of oncology therapeutic clinical trials, and combined with the clinical data standards established by the Clinical Data Interchange Standards Consortium (CDISC) and the issued industrial guidelines, this article introduces the general considerations of clinical data management for oncology clinical trials, with the aim of emphasizing normative data collection and timely data monitoring to ensure the data quality and reliability of results of the study. This article discusses the impact of complex study design on CRF, design CRF according to CDASH, develop DVP scientifically, rolling submissions and data cut-off.
3.Next-generation ALK-TKI in NSCLC patients
Bo YAN ; Yu DONG ; Bo ZHANG ; Xueyan ZHANG ; Tianqing CHU ; Shuyuan WANG ; Baohui HAN
Journal of Chinese Physician 2018;20(12):1814-1816
Objective The aim of the study is to investigate the therapeutic efficacy of next-generation anaplastic lynphoma kinase-tyrosine kinase inhibitor (ALK-TKI) in advanced non-small cell lung cancer (NSCLC).Methods The clinical data and outcomes of 22 patients with advanced non-small cell lung cancer who received the next generation of ALK-TKI from 2014 to 2017 in our hospital were retrospectively analyzed.Results 22 patients were included for survival analysis with 15 males and 7 females.The median age was 48 and all of them were adenocarcinoma patients.There were 12,2,7 and 1 patients received ceritinib,alectinib,brigatinib and lorlatinib,respectively.A total of 14 patients could be evaluated,including complete response (CR) in 2 cases,partial response (PR) in 3 cases,stable disease (SD) in 6 cases,progressive disease (PD) in 3 cases.The ORR and DCR were 35.7% and 78.6%,respectively.The median progression free survival (PFS) of the 22 NSCLC patients was 8.7 months.Progression pattern can be analyzed in 17 patients.Among them,10 patients underwent primary progression (lung),occurring at the leading frequency (accounting for 58.8%) and followed by central nerve system (CNS) progression (accounting for 29.4%).Conclusions Next-generation ALK-TKI provide a reasonable choice for crizotinib-resistant patients.Primary progression (lung) is the leading cause for treatment failure.Multi-disciplinary integration may provide a potential choice for prolonging administration of next-generation ALK-TKI.
4.Preparation of cinnamomi cortex oil microspheres based on porous silicon dioxide and its property characterizations.
Chun-Xia ZHU ; Yan-Rong JIANG ; Zhen-Hai ZHANG ; Dong-Mei DING ; Xiao-Bin JIA
China Journal of Chinese Materia Medica 2013;38(20):3479-3483
To determine the optimum process for preparing Cinnamomi Cortex oil microspheres based on porous silicon dioxide. After porous silica dioxide adsorbed Cinnamomi Cortex oil, Cinnamomi Cortex oil microspheres were prepared by the dropping method, with sodium alginate as the skeleton materials. The preparation process was optimized through the L(9) (3(4)) orthogonal test design, with microspheres diameter, distribution, drug loading capacity and entrapment efficiency as the indexes. The cinnamon volatile oil microspheres were characterized by scanning election microscope (SEM), thermogravimetric analysis (TGA), and infrared (IR) spectroscopy. An in vitro drug release experiment was conducted. The results showed that the microspheres prepared with the optimal process parameters were in good shape, even in size and good in dispersibility, with an average diameter of 1.61 mm, an average drug loading capacity of 32.85%, an entrapment efficiency of 94.79%. The maximum drug release capacity reached 72.6%, 95.0%, 97.4%, respectively, under pH 4.0, 6.8, 7.4 in 6 hours. Meanwhile, microsphere generation was tested by IR, TGA and other methods. The established optimum process for preparing Cinnamomi Cortex oil microspheres was proved to be stable and practical.
Alginates
;
chemistry
;
Chemistry, Pharmaceutical
;
Cinnamomum
;
chemistry
;
Drug Carriers
;
chemistry
;
Drugs, Chinese Herbal
;
chemistry
;
Glucuronic Acid
;
chemistry
;
Hexuronic Acids
;
chemistry
;
Microspheres
;
Particle Size
;
Porosity
;
Silicon Dioxide
;
chemistry
;
Solubility
5.Mechanism analysis of repeatedly steamed and sundried Rehmanniae Radix Praeparata in delaying brain aging in ovariectomized mice based on proteomics.
Fei-Xia YAN ; Xu-Dong ZHU ; Song WANG ; Wei YAO ; Yong-Yan XIE ; Rui-Qing ZHOU ; Yao-Hui CHEN ; Yi WU ; Li-Ping HUANG
China Journal of Chinese Materia Medica 2022;47(1):141-150
The present study explored the effect and mechanism of repeatedly steamed and sundried Rehmanniae Radix Praeparata(RRP) in delaying brain aging in ovariectomized mice. After ovariectomy, the mice were randomly divided into a model group, an estradiol valerate group(0.3 mg·kg~(-1)), and low-(1.0 g·kg~(-1)), medium-(2.0 g·kg~(-1)), and high-dose(4.0 g·kg~(-1)) RRP groups, and a sham operation group was also set up, with 15 mice in each group. One week after the operation, intragastric administration was carried out for 15 consecutive weeks. The step-down test and Morris water maze test were used to detect the behavioral changes of mice. HE staining and Nissl staining were used to observe the morphological changes of mouse brain tissues. Immunohistochemistry was used to detect the expression of Aβ and ER_β in mouse brain tissues. The serum estrogen levels and cholinesterase and cholinesterase transferase levels in brain tissues of mice were detected by assay kits. The extracted hippocampal protein was detected by the Nano-ESI-LC-MS system, identified by the Protein Discovery, and analyzed quantitatively and qualitatively by the SIEVE. The PANTHER Classification System was used for GO analysis and KEGG pathway enrichment analysis of the differential proteins. Compared with the sham operation group, the model group showed decreased learning and memory ability, shortened step-down latency(P<0.05), prolonged escape latency(P<0.05), reduced platform crossings and residence time in the target quadrant, scattered nerve cells in the hippocampus with enlarged intercellular space, increased expression of Aβ-positive cells(P<0.05), declining expression of ER_β-positive cells and estrogen level(P<0.05), and weakened cholinergic function(P<0.05). Compared with the model group, the RRP groups showed improved learning and memory ability, prolonged step-down latency(P<0.05), increased estrogen level(P<0.05), neatly arranged nerve cells in the hippocampus with complete morphology, declining Aβ-positive cells, and elevated expression of ER_β-positive cells. A total of 146 differential proteins were screened out by proteomics, and KEGG pathway enrichment yielded 75 signaling pathways. The number of proteins involved in the dopaminergic synapse signaling pathway was the largest, with 13 proteins involved. In summary, RRP can delay brain aging presumedly by increasing the level of estrogen, mediating the dopaminergic synapse signaling pathway, and improving cholinergic function.
Aging
;
Animals
;
Female
;
Hippocampus/metabolism*
;
Learning
;
Mice
;
Plant Extracts
;
Proteomics
;
Rehmannia